In brief
In a significant ruling, the Ninth Circuit Court of Appeals upheld Elizabeth Holmes' conviction for defrauding investors of Theranos, reinforcing the reality of her questionable business practices while stating her claims were based on deceitful narratives.
In a recent court decision, Elizabeth Holmes, founder of the controversial blood-testing startup Theranos, faced a setback as her appeal against her fraud conviction was rejected. Holmes, who was sentenced to over 11 years in prison for misleading investors about her company's financial status and technology efficacy, failed to sway the Ninth Circuit Court of Appeals, which dismissed her arguments regarding trial evidence and the testimony of her former partner, Ramesh "Sunny" Balwani.Judge Jacqueline H Nguyen, on behalf of the three-judge panel, criticized the claims made by Holmes and Balwani, branding the promise of conducting blood tests with just a drop of blood as a deceptive "mirage." Holmes was found guilty in 2022 on multiple counts of conspiracy and wire fraud, and her former business partner Balwani, who received a different sentencing, also lost his appeal.Holmes maintained that Balwani's statements indicating he bore the responsibility for Theranos' financial inaccuracies should have been included in her trial. The court ultimately sided against her, firmly stating that none of the argued points regarding improper testimonies or the admissibility of evidence warranted a different outcome.Once hailed as a Silicon Valley darling with an estimated valuation of $9 billion, Theranos was plunged into scandal after investigative reports unveiled serious flaws in its technology, leading to criminal indictments for both Holmes and Balwani. Holmes began her prison sentence in Texas earlier this year, and both she and Balwani continue to face financial repercussions from court-ordered restitution totaling $452 million to victims of their fraudulent schemes.



